EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Early skeletal muscle deconditioning and reduced exercise capacity during (neo)adjuvant chemotherapy in patients with breast cancer

Joris Mallard, Elyse Hucteau, Roland Schott, Philippe Trensz, Carole Pflumio, Michal Kalish-Weindling, Fabrice Favret, Xavier Pivot, Thomas J Hureau, Allan F Pagano iD

Cancer · 15.01.2023 · 129 (2) · 215-225

DOI: 10.1002/cncr.34533 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer, online erschienen am 17.11.2022. Verfasst von Joris Mallard und 9 weiteren Autor:innen. Beteiligte Einrichtung: Biomedicine Research Centre of Strasbourg (CRBS), Mitochondria, oxidative stress, and muscular protection laboratory (UR 3072), Strasbourg, France. Hauptthemen laut MEDLINE: Hand Strength, Breast Neoplasms. Die Arbeit wurde bisher 46-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Université de Strasbourg.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Fatigue is a hallmark of breast cancer and is associated with skeletal muscle deconditioning. If cancer‐related fatigue occurs early during chemotherapy (CT), the development of skeletal muscle deconditioning and its effect on exercise capacity remain unclear. The aim of this study was to investigate the evolution of skeletal muscle deconditioning and exercise capacity in patients with early‐stage breast cancer during CT.

Methods

Patients with breast cancer had a visit before undergoing CT, at 8 weeks, and at the end of chemotherapy (post‐CT). Body composition was determined through bioelectrical impedance analysis. Knee extensor, handgrip muscle force and fatigue was quantified by performing maximal voluntary isometric contractions and exercise capacity using the 6‐min walking test. Questionnaires were also administered to evaluate quality of life, cancer‐related fatigue, and physical activity level.

Results

Among the 100 patients, reductions were found in muscle mass (−2.3%, p = .002), exercise capacity (−6.7%, p < .001), and knee extensor force (−4.9%, p < .001) post‐CT, which occurred within the first 8 weeks of treatment with no further decrease thereafter. If muscle fatigue did not change, handgrip muscle force decreased post‐CT only (−2.5%, p = .001), and exercise capacity continued to decrease between 8 weeks and post‐CT (−4.6%, p < .001). Quality of life and cancer‐related fatigue were impaired after 8 weeks ( p < .001) and remained stable thereafter, whereas the physical activity level remained stable during chemotherapy.

Conclusions

Similar to cancer‐related fatigue, skeletal muscle deconditioning and reduced exercise capacity occurred early during breast cancer CT. Thus, it appears essential to prevent these alterations through exercise training implemented during CT.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hand StrengthBreast NeoplasmsHumansFemaleExercise ToleranceQuality of LifeMuscle, SkeletalChemotherapy, Adjuvant

Stichwörter der Autor:innen

cancer-related fatigueexercise capacitymuscle atrophymuscle fatiguemuscle force

Autor:innen und Institutionen

  • Biomedicine Research Centre of Strasbourg (CRBS), Mitochondria, oxidative stress, and muscular protection laboratory (UR 3072), Strasbourg, France.
  • Faculty of Sport Sciences, European Centre for Education, Research and Innovation in Exercise Physiology (CEERIPE), University of Strasbourg, Strasbourg, France.
  • Institute of Cancerology Strasbourg Europe (ICANS), Strasbourg, France.

ORCID-Profile: Allan F Pagano

Förderung

  • Université de Strasbourg

Zitieren

APA

Mallard, J., Hucteau, E., Schott, R., Trensz, P., Pflumio, C., Kalish-Weindling, M., Favret, F., Pivot, X., Hureau, T. J., & Pagano, A. F. (2023). Early skeletal muscle deconditioning and reduced exercise capacity during (neo)adjuvant chemotherapy in patients with breast cancer. Cancer, 129(2), 215-225. https://doi.org/10.1002/cncr.34533

Vancouver

Mallard J, Hucteau E, Schott R, Trensz P, Pflumio C, Kalish-Weindling M, et al. Early skeletal muscle deconditioning and reduced exercise capacity during (neo)adjuvant chemotherapy in patients with breast cancer. Cancer. 2023;129(2):215-225. doi:10.1002/cncr.34533

BibTeX
@article{Mallard2023,
  author = {Mallard, Joris and Hucteau, Elyse and Schott, Roland and Trensz, Philippe and Pflumio, Carole and Kalish-Weindling, Michal and Favret, Fabrice and Pivot, Xavier and Hureau, Thomas J and Pagano, Allan F},
  title = {Early skeletal muscle deconditioning and reduced exercise capacity during (neo)adjuvant chemotherapy in patients with breast cancer},
  journal = {Cancer},
  year = {2023},
  volume = {129},
  number = {2},
  pages = {215--225},
  doi = {10.1002/cncr.34533}
}
Kostenlos starten →